The infusion method trial of void vs standard catheter removal in the outpatient setting: a prospective randomized trial

被引:15
作者
Boccola, Mark A. [1 ]
Sharma, Anant [1 ]
Taylor, Claire [1 ]
Wong, Lih-Ming [1 ]
Travis, Douglas [1 ]
Chan, Steven [1 ]
机构
[1] Univ Melbourne, Dept Surg, Western Hosp, Footscray, Vic 3011, Australia
关键词
trial of void (TOV); acute urinary retention (AUR); outpatient setting; urinary catheter; discharge time; ACUTE URINARY RETENTION; INTRAVESICAL PROSTATIC PROTRUSION; TRANSURETHRAL RESECTION; FOLLOW-UP; PROSTATECTOMY; MANAGEMENT; ALFUZOSIN; PLACEBO; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2011.10044.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE center dot To ascertain if filling the bladder with warm normal saline before trial of void (TOV) reduces time to decision of outcome of TOV and time to discharge compared with standard in-dwelling catheter (IDC) removal in the outpatient setting. PATIENTS AND METHODS center dot A prospective randomized controlled trial (not blinded) was carried out in the day procedure unit. Randomization was done using computer-generated random numbers. The sample size was calculated based on initial pilot data using alpha = 0.05 and beta = 0.2 and a clinically important reduction of >= 60 min for time to decision of outcome of TOV (primary outcome measure). center dot In all, 60 consecutive patients were recruited from two referral sources: presentations of acute urinary retention to the emergency department and patients discharged home after failing TOV postoperatively. center dot The infusion method group (32 patients) had 300-500 mL warm normal saline infused into the bladder before removing their IDC and the control group (28) had standard IDC removal. center dot Data were collected and analysed using the two-tailed Mann-Whitney U-test. Statistical significance was set at P < 0.05. RESULTS center dot The median time to decision was 135.0 (95% confidence interval CI 95.0-190.0) min in the infusion group and 247.5 (95% CI 189.6-294.1) min in the control group. center dot Patients undergoing a bladder infusion had a shorter discharge time [180.0 (95% CI 126.0-226.9) min] than patients in the standard-IDC-removal group [262.5 (95% CI 233.8-315.0) min]. center dot The infusion arm shortened time to decision by 112.5 min (P < 0.001) and time to discharge by 82.5 min (P < 0.001). center dot Furthermore, patients in the infusion group were 1.56 times more likely to achieve catheter-free state after TOV (risk ratio 1.56, 95% CI 1.03-2.36; P = 0.03). CONCLUSION center dot The infusion method for TOV is safe and expeditious, making it ideal for the outpatient setting. This randomized study shows that the infusion method enables a rapid determination of outcome of TOV with a greater chance of success and shortened discharge times.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 23 条
[1]   The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis [J].
Annemans, L ;
Cleemput, I ;
Lamotte, M ;
McNeill, A ;
Hargreave, T .
BJU INTERNATIONAL, 2005, 96 (04) :566-571
[2]   CRITICAL EVALUATION OF RESULTS OF TRANS-URETHRAL RESECTION OF PROSTATE [J].
CHILTON, CP ;
MORGAN, RJ ;
ENGLAND, HR ;
PARIS, AMI ;
BLANDY, JP .
BRITISH JOURNAL OF UROLOGY, 1978, 50 (07) :542-546
[3]   Urodynamic assessment of patients with acute urinary retention: Is treatment failure after prostatectomy predictable? [J].
Djavan, B ;
Madersbacher, S ;
Klingler, C ;
Marberger, M .
JOURNAL OF UROLOGY, 1997, 158 (05) :1829-1833
[4]   Natural history of prostatism: Risk factors for acute urinary retention [J].
Jacobsen, SJ ;
Jacobson, DJ ;
Girman, CJ ;
Roberts, RO ;
Rhodes, T ;
Guess, HA ;
Lieber, MM .
JOURNAL OF UROLOGY, 1997, 158 (02) :481-487
[5]   Influence of transient overdistension on bladder wall morphology and enzyme histochemistry [J].
Leppilahti, M ;
Hirvonen, J ;
Tammela, TLJ .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1997, 31 (06) :517-522
[6]   Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia [J].
Lucas, MG ;
Stephenson, TP ;
Nargund, V .
BJU INTERNATIONAL, 2005, 95 (03) :354-357
[7]   FOLLOW-UP AFTER TRANSURETHRAL RESECTION OF PROSTATE - WHO NEEDS IT [J].
LYNCH, TH ;
WAYMONT, B ;
BEACOCK, CJM ;
DUNN, JA ;
HUGHES, MA ;
WALLACE, DMA .
BRITISH MEDICAL JOURNAL, 1991, 302 (6767) :27-27
[8]   The infusion trial of micturition [J].
Lyth, DR ;
Braslis, K ;
Iacovou, JW .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (01) :94-95
[9]   FURTHER STUDY OF THE INCREASED MORTALITY FOLLOWING TRANSURETHRAL PROSTATECTOMY - A CHART-BASED ANALYSIS [J].
MALENKA, DJ ;
ROOS, N ;
FISHER, ES ;
MCLERRAN, D ;
WHALEY, FS ;
BARRY, MJ ;
BRUSKEWITZ, R ;
WENNBERG, JE ;
WHITE, C ;
MEBUST, WK ;
HOLTGREWE, HL .
JOURNAL OF UROLOGY, 1990, 144 (02) :224-228
[10]   PROSTATECTOMY - PATIENTS PERCEPTION AND LONG-TERM FOLLOW-UP [J].
MALONE, PR ;
COOK, A ;
EDMONSON, R ;
GILL, MW ;
SHEARER, RJ .
BRITISH JOURNAL OF UROLOGY, 1988, 61 (03) :234-238